PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - Cancer risk from nitrosamine-contaminated valsartan
AID  - 10.1136/dtb.2021.000041
DP  - 2021 Oct 01
TA  - Drug and Therapeutics Bulletin
PG  - 147--147
VI  - 59
IP  - 10
4099  - http://dtb.bmj.com/content/59/10/147.short
4100  - http://dtb.bmj.com/content/59/10/147.full
SO  - Drug Ther Bull2021 Oct 01; 59
AB  - Overview of: Gomm W, Röthlein C, Bowl K, et al. Valsartan contaminated with N-nitrosodimethylamine and cancer risk: a longitudinal cohort study with German health insurance data. Dtsch Arztebl Int 2021; 118:357–62. doi: 10.3238/arztebl.m2021.0129.